학술논문
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.
Document Type
Article
Author
Ujjani, Chaitra; Mato, Anthony; Hill, Brian T; Allan, John N; Lansigan, Frederick; Jacobs, Ryan; Skarbnik, Alan; Tuncer, Hande; Pagel, John; Brander, Danielle; Cheson, Bruce; Barr, Paul; Roeker, Lindsey E; Pu, Jeffrey; Shah, Nirav N; Goy, Andre; Schuster, Stephen J; Lamanna, Nicole; Sehgal, Alison; Tam, Constantine S
Source
Blood & Lymphatic Cancer: Targets & Therapy; Aug2020, Vol. 10, p1-5, 5p
Subject
Language
ISSN
11799889
Abstract
Copyright of Blood & Lymphatic Cancer: Targets & Therapy is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)